Gain Therapeutics GANX Cash Flow Statement (2020-2026)

NASDAQ GANX
$1.98 -0.09 (-4.35%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-4.66M-3.22M-3.27M-5.09M-4.56M12.67M-5.14M-7.69M-4.72M-5.01M-4.01M-8.14M-4.49M-3.77M-4.53M-5.81M-5.28M0.38M-5.61M-4.68M
Depreciation and Depletion (Quarter)
0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.01M0.01M
Share-based Compensation (Quarter)
0.25M0.29M0.31M0.31M0.36M0.56M0.57M1.32M0.82M0.56M0.15M1.48M0.36M0.46M0.42M0.53M3.50M0.39M0.06M0.57M
Deferred Taxes (Quarter)
-0.04M-0.05M-0.06M-0.12M-0.02M-608.00-0.06M1.65M-0.13M-0.38M0.04M-181.00236.00-0.90M-0.09M-0.21M-0.02M-0.01M
Cash from Operations (Quarter)
-2.19M-4.15M-2.45M-5.05M-3.29M-3.90M-4.22M-5.02M-3.97M-5.66M-3.59M-5.76M-6.08M-3.45M-3.82M-5.10M-4.93M-4.62M-4.73M-4.68M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.00M0.01M0.01M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.02M0.03M0.02M0.03M
Change in Working Capital
Change in Receivables (Quarter)
-0.33M-0.02M
Change in Account Payables (Quarter)
1.54M
Change in Accured Expenses (Quarter)
1.16M-0.59M1.74M-0.51M0.30M-0.82M1.06M-0.68M-0.05M-1.03M0.70M1.48M-1.85M-0.06M1.11M0.15M-0.95M-0.79M0.53M-0.49M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
-1.72M1.38M-0.51M1.38M-2.05M1.29M-0.46M-1.37M0.01M1.77M-0.42M-1.05M2.19M-0.36M-0.16M1.41M-0.77M-0.40M0.28M0.22M
Investing Activities
Capital Expenditures (Quarter)
0.32M-0.40M0.01M0.04M-0.20M0.16M0.01M0.00M650.0019.000.00M0.00M0.02M-548.00-927.00-851.00-541.00-533.00913.00-0.01M
Change in Acquisitions & Divestments (Quarter)
2.07M4.07M3.05M1.93M3.14M3.02M2.02M-0.04M
Cash from Investing Activities (Quarter)
-0.03M-0.01M-0.01M-14.89M-0.01M0.13M2.11M3.05M1.93M3.14M3.02M2.00M-1.00-0.04M
Financing Activities
Other financing activities (Quarter)
-42.62M0.06M0.06M0.04M1.30M0.00M
Cash from Financing Activities (Quarter)
-0.01M-0.04M0.00M-0.02M-0.02M0.75M2.20M0.13M9.56M-0.15M10.04M0.81M2.31M2.40M2.47M7.03M16.55M0.40M1.37M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
0.77M2.22M0.16M0.75M5.64M8.30M7.57M13.64M0.40M1.50M
Additional items
Exchange Rate Effect (Quarter)
0.03M0.06M-0.05M-0.09M-0.11M0.23M0.04M0.11M-0.14M0.48M-0.44M0.01M0.38M-0.48M0.11M0.26M0.01M0.10M0.02M-0.14M
Change in Cash (Quarter)
-2.19M-4.10M-2.54M-20.03M-3.43M-3.57M-1.32M0.33M-2.05M7.53M-1.16M6.30M-4.88M-1.67M-1.31M-2.37M2.11M12.03M-4.30M-3.46M
Free Cash Flow (Quarter)
-2.51M-3.74M-2.46M-5.10M-3.08M-4.06M-4.23M-5.03M-3.97M-5.66M-3.59M-5.76M-6.09M-3.45M-3.82M-5.10M-4.93M-4.62M-4.73M-4.67M
Net Cash Flow (Quarter)
-2.22M-4.17M-2.49M-19.94M-3.32M-3.79M-1.36M0.22M-1.90M7.04M-0.71M6.28M-5.27M-1.19M-1.42M-2.63M2.11M11.93M-4.32M-3.31M